NO982902L - FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen - Google Patents

FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen

Info

Publication number
NO982902L
NO982902L NO982902A NO982902A NO982902L NO 982902 L NO982902 L NO 982902L NO 982902 A NO982902 A NO 982902A NO 982902 A NO982902 A NO 982902A NO 982902 L NO982902 L NO 982902L
Authority
NO
Norway
Prior art keywords
gestagen
combination
strogen
mammals including
preparation kit
Prior art date
Application number
NO982902A
Other languages
English (en)
Other versions
NO982902D0 (no
Inventor
Jan Endrikat
Bernd Duesterberg
Pia Reilhac
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO982902L publication Critical patent/NO982902L/no
Publication of NO982902D0 publication Critical patent/NO982902D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO982902A 1995-12-23 1998-06-22 FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen NO982902D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19549264A DE19549264A1 (de) 1995-12-23 1995-12-23 Verfahren und Kit zur Kontrazeption
PCT/DE1996/002486 WO1997023228A2 (de) 1995-12-23 1996-12-20 Verfahren und kit zur kontrazeption bei weiblichen säugern, bestehend aus einer kombination von gestagen und estrogen

Publications (2)

Publication Number Publication Date
NO982902L true NO982902L (no) 1998-06-22
NO982902D0 NO982902D0 (no) 1998-06-22

Family

ID=7781724

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982902A NO982902D0 (no) 1995-12-23 1998-06-22 FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen

Country Status (23)

Country Link
US (1) US6995149B1 (no)
EP (1) EP0868188B1 (no)
JP (1) JP2000502108A (no)
KR (1) KR19990076685A (no)
AT (1) ATE244567T1 (no)
AU (1) AU716249B2 (no)
BR (1) BR9612207A (no)
CA (1) CA2241192A1 (no)
CZ (1) CZ291743B6 (no)
DE (2) DE19549264A1 (no)
DK (1) DK0868188T3 (no)
ES (1) ES2202498T3 (no)
HU (1) HUP9901662A3 (no)
IL (1) IL124472A (no)
IS (1) IS4753A (no)
MX (1) MX9804395A (no)
NO (1) NO982902D0 (no)
NZ (1) NZ330741A (no)
PL (1) PL187180B1 (no)
PT (1) PT868188E (no)
SK (1) SK79298A3 (no)
UA (1) UA59356C2 (no)
WO (1) WO1997023228A2 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
CN1270521A (zh) * 1997-09-12 2000-10-18 美国家用产品公司 第一阶段包含孕激素/***并且第二阶段包含孕激素的口服避孕制剂
EP1535618A1 (en) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
DE102008036825A1 (de) * 2008-08-05 2010-02-11 Aicuris Gmbh & Co. Kg Schwangerschaftsvermeidung durch Gestagene
CA2740004A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
CA2740005C (en) * 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
US9198876B2 (en) * 2008-10-08 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
EP2410859A4 (en) * 2009-03-27 2013-03-13 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
JP5954736B2 (ja) * 2011-01-12 2016-07-20 国立大学法人 宮崎大学 難治性炎症性腸疾患の予防又は治療方法
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368373A1 (en) 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
UA48973C2 (uk) * 1995-06-07 2002-09-16 Орто-Макнейл Фармасьютікалз Інк. Трансдермальний пластир на основі 17-деацетилноргестимату для попередження овуляції
US6139873A (en) * 1996-07-10 2000-10-31 Cedars-Sinai Medical Center Combined pharmaceutical estrogen-androgen-progestin
US5770226A (en) * 1996-07-10 1998-06-23 Wake Forest University Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US6479475B1 (en) * 1996-07-26 2002-11-12 Wyeth Oral contraceptive
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
AU758144B2 (en) * 1998-08-17 2003-03-13 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon, The Gene regulating circadian clock function and photoperiodism

Also Published As

Publication number Publication date
EP0868188B1 (de) 2003-07-09
AU716249B2 (en) 2000-02-24
ATE244567T1 (de) 2003-07-15
UA59356C2 (uk) 2003-09-15
PT868188E (pt) 2003-11-28
NO982902D0 (no) 1998-06-22
PL187180B1 (pl) 2004-05-31
CZ291743B6 (cs) 2003-05-14
NZ330741A (en) 2000-03-27
IL124472A (en) 2001-07-24
BR9612207A (pt) 1999-07-13
IS4753A (is) 1998-05-22
JP2000502108A (ja) 2000-02-22
ES2202498T3 (es) 2004-04-01
HUP9901662A2 (hu) 1999-09-28
MX9804395A (es) 1998-09-30
EP0868188A2 (de) 1998-10-07
PL327182A1 (en) 1998-11-23
CZ9802000A3 (cs) 1998-11-11
HUP9901662A3 (en) 1999-11-29
DE59610600D1 (de) 2003-08-14
US6995149B1 (en) 2006-02-07
AU1921997A (en) 1997-07-17
CA2241192A1 (en) 1997-07-03
KR19990076685A (ko) 1999-10-15
DK0868188T3 (da) 2003-10-06
WO1997023228A3 (de) 1997-08-28
DE19549264A1 (de) 1997-06-26
IL124472A0 (en) 1998-12-06
WO1997023228A2 (de) 1997-07-03
SK79298A3 (en) 2000-06-12

Similar Documents

Publication Publication Date Title
NO982902L (no) FremgangsmÕte og preparatsett for Õ hindre befruktning hos hunn-pattedyr som omfatter en kombinasjon av gestagen og °strogen
TR199802705T2 (xx) Progestojen-anti-progestojen k�r�
NO976067L (no) Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon
ES2174920T3 (es) Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno.
EP0136011A3 (en) A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
PL327146A1 (en) Antagonists of the gonadotrophin liberating hormone
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
PL319373A1 (en) Method of producing single doses by wet granulation
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
NZ333750A (en) Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
ATE91410T1 (de) Osmotische dosierungsform.
UA33487A (uk) Спосіб лікування підгострих запалювальних захворювань придатків матки
MX9703018A (es) Antagonistas de progesterona competentes para regular la fertilidad femenina segun se requiera.
MX9804819A (es) Antagonistas de hormona liberadora de gonadotropina.